Cargando…

A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma

PURPOSE: To construct and test a hepatocellular carcinoma (HCC)-targeted magnetic resonance probe based on a glypican-3 (GPC3)-specific aptamer (AP613-1) with ultrasmall superpara-magnetic iron oxide (USPIO). METHODS: Oleic acid-coated USPIO nanoparticles were modified with amino polyethylene glycol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Menglong, Liu, Zhuang, Dong, Lili, Zhou, Hongxin, Yang, Shuohui, Wu, Weizhong, Lin, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078089/ https://www.ncbi.nlm.nih.gov/pubmed/30122918 http://dx.doi.org/10.2147/IJN.S168268

Ejemplares similares

Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging
por: Dong, Lili, et al.
Publicado: (2018)

Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
por: Park, Jun Young, et al.
Publicado: (2020)

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2023)

Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma
por: Li, Youwei, et al.
Publicado: (2012)

GPC-3 in hepatocellular carcinoma: current perspectives
por: Wu, Yongle, et al.
Publicado: (2016)

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
por: Ofuji, Kazuya, et al.
Publicado: (2014)

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
por: Li, You-Cai, et al.
Publicado: (2018)

Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
por: Xia, Lijie, et al.
Publicado: (2020)

Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
por: Bi, Yanyu, et al.
Publicado: (2017)

Optimization of GPC3-specific chimeric antigen receptor structure and its effect on killing hepatocellular carcinoma cells
por: Zhao, Jianfeng, et al.
Publicado: (2021)

Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
por: Ma, Xiao-Hong, et al.
Publicado: (2019)

AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation
por: Bian, Xinyu, et al.
Publicado: (2021)

Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma
por: Meng, Min, et al.
Publicado: (2021)

Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinoma
por: Shin, Woo-Ri, et al.
Publicado: (2022)

Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular Carcinoma
por: Li, Jingwen, et al.
Publicado: (2022)

The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma
por: Yi, Bin, et al.
Publicado: (2021)

Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
por: Wang, Yuliang, et al.
Publicado: (2011)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
por: LUO, CHENHONG, et al.
Publicado: (2014)

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
por: Sawada, Yu, et al.
Publicado: (2016)

Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma
por: Yi, Bin, et al.
Publicado: (2021)

GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma
por: Ramadan, Amany, et al.
Publicado: (2023)

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2018)

Adaptive PIF Control for Permanent Magnet Synchronous Motors Based on GPC
por: Lu, Shaowu, et al.
Publicado: (2012)

Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model
por: Ma, Xiao-Hong, et al.
Publicado: (2022)

Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment
por: Zhao, Dongxu, et al.
Publicado: (2022)

Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
por: Jiang, Zhiwu, et al.
Publicado: (2017)

Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles
por: Deng, Han, et al.
Publicado: (2022)

Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
por: Mauro, Montalbano, et al.
Publicado: (2023)

An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice
por: Lin, Bing-Quan, et al.
Publicado: (2021)

GPC3 reduces cell proliferation in renal carcinoma cell lines
por: Valsechi, Marina Curado, et al.
Publicado: (2014)

GPC6 Promotes Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma
por: Fan, Chunmei, et al.
Publicado: (2019)

Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy
por: Shi, Yaoping, et al.
Publicado: (2023)

Magnetic resonance imaging for characterization of hepatocellular carcinoma metabolism
por: Wang, Lixia, et al.
Publicado: (2022)

Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
por: Zeng, Zihua, et al.
Publicado: (2014)

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)

Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments
por: Li, Weiyue, et al.
Publicado: (2018)

Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression
por: Li, Jian, et al.
Publicado: (2019)

Fluorescence imaging of hepatocellular carcinoma with a specific probe of COX-2
por: Wang, Haibo, et al.
Publicado: (2018)

Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells
por: Yu, Xiao-Xia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_urfiooiut7ms3link3ld5gdl85